UNH — UnitedHealth Group Incorporated stock price, charts and financials

QT77UnitedHealth Group Incorporated

UnitedHealth Group Incorporated (NYSE: UNH) is a Healthcare company in the Medical - Healthcare Plans industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
411.04
+3.96+0.97%
UNHQT77UnitedHealth Group Incorporated·NYSE
411.04+0.97%
News
Up 1.0% — UNH Leads Its Peer Group. You Pay For That (Yahoo).
Medium confidence
TA
Loading chart...
Signal & projected range
Insider open-market saleHistorical pattern — not a prediction
Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)
Horizon
0%Past 3 monthsToday
Unlock the projected rangeSee where this setup landed historically — with Premium.

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Premium shows the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands ofhistorical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →
Snapshot
IndexS&P 500, DJIAP/E26.18EPS (ttm)15.55Insider Own0.19%Shs Outstand908.14MPerf Week-1.77%
Market Cap369.69BForward P/E18.16EPS next Y22.42Insider Trans-0.07%Shs Float906.11MPerf Month-5.70%
Enterprise Value411.55BPEG-EPS next Q4.06Inst Own88.20%Short Float1.91%Perf Quarter10.10%
Income14.16BP/S0.82EPS this Y26.79%Inst Trans-Short Ratio2.43Perf Half Y51.58%
Sales450.12BP/B3.53EPS next Y13.69%ROA4.56%Short Interest17.34MPerf YTD23.32%
Book/sh-P/C13.65EPS next 5Y14.84%ROE14.40%52W High466.08 -11.81%Perf Year65.63%
Cash/sh-P/FCF15.65EPS past 3/5Y-14.52% -3.77%ROIC6.84%52W Low241.83 69.97%Perf 3Y-19.36%
Dividend Est.9.28 (2.26%)EV/EBITDA15.97Sales past 3/5Y11.35% 11.72%Gross Margin22.49%Volatility2.85% 3.01%Perf 5Y-1.25%
Dividend TTM8.95 (2.18%)EV/Sales0.91EPS Y/Y TTM0.26%Oper. Margin4.82%ATR (14)12.08Perf 10Y185.15%
Dividend Ex-DateJun 15, 2026Quick Ratio1.24Sales Y/Y TTM12.45%Profit Margin3.14%RSI (14)43.98Recom2.21
Dividend Gr. 3/5Y10.90% 12.57%Current Ratio1.24EPS Q/Q56.37%SMA20-3.14%Beta0.61Target Price473.89
Payout57.33%Debt/Eq0.70Sales Q/Q0.37%SMA50-1.39%Rel Volume0.64Prev Close407.08
Employees390,000LT Debt/Eq0.71EarningsOct 27SMA20017.68%Avg Volume6.34MPrice411.04
IPO DateOct 17, 1984Option/ShortYes / YesEPS/Sales Surpr.30.01% 1.11%Net Debt/EBITDA1.62Volume4,087,860Change0.97%
Analyst Ratings
DateActionAnalystRatingTarget
Jul-21-26ReiteratedBMO CapitalMarket Perform$512
Jul-21-26ReiteratedD.A. Davidson$512
Jul-20-26ReiteratedWells FargoOverweight$485$526
Jul-20-26ReiteratedBarclaysOverweight$429$441
Jul-17-26ReiteratedKeybancOverweight$475$500
Jul-17-26ReiteratedTruist SecuritiesBuy$480$500
Jul-17-26ReiteratedUBSBuy$460$490
Jul-17-26ReiteratedMorgan StanleyOverweight$468$529
Jul-16-26ReiteratedRobert W. Baird$198$453
Jul-16-26ReiteratedPiper SandlerOverweight$475$477
Latest News
Aug-07-26
Aug-06-26
Aug-05-26
Aug-03-26
Aug-03-2612:15PM
Jul-31-26
Jul-29-26
Company

UnitedHealth Group Incorporated (UNH) operates as a comprehensive healthcare enterprise across the United States, structuring its diverse services into four key divisions: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment provides a wide array of health benefit plans and consumer-focused services. These offerings cater to a broad spectrum of clients, including large national corporations, public sector employers, mid-sized and small businesses, and individual consumers. It also delivers specialized health coverage and wellness programs tailored for individuals aged 50 and older, addressing their needs for preventive and acute care, chronic disease management, and other age-specific health issues. This division further encompasses Medicaid plans, children's health insurance, dental benefits, and various hospital and clinical services. Optum Health focuses on delivering direct healthcare solutions and management services. It facilitates access to networks of specialist care providers, offers health management programs, direct care delivery, consumer engagement initiatives, and financial services. Its diverse clientele includes individuals (served directly through care systems), employers, insurance payers, and government organizations. Optum Insight specializes in providing technology, information, and consulting services to the healthcare industry. Its offerings include software and data products, advisory consulting arrangements, and outsourced managed services. Clients span hospital systems, physicians, health plans, governmental bodies, life sciences companies, and other relevant organizations. Finally, Optum Rx handles the company's pharmaceutical care services. This segment manages retail pharmacy networks, provides home prescription delivery, and offers specialty and compounding pharmacy capabilities. Leveraging its purchasing power and clinical expertise, Optum Rx also develops advanced programs related to step therapy, formulary management, medication adherence, and integrated disease and drug therapy management. UnitedHealth Group Incorporated, founded in 1977, has its corporate headquarters located in Minnetonka, Minnesota.

Ownership
Total institutional ownership88.20%

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue450,129447,567400,278
Cost of Goods Sold Incl. D&A348,915364,650310,879
Gross Profit101,21482,91789,399
Selling, General and Administrative Excl. Other
15,39000
Research and Development
000
Other Operating Expense64,14863,95357,112
Operating Income21,67618,96432,287
Interest Expense3,8944,0023,906
Unusual Expense
Non-Operating Income (Expense)-342-265-8,310
Net Income Before Taxes17,44014,69720,071
Income Taxes2,5281,8904,829
Consolidated Net Income14,12212,05614,405
Net Income From Continuing Operations14,91212,80715,242
Net Income14,12212,05614,405
EPS (Recurring)15.5513.2315.64
EPS (Basic, Before Extraordinaries)15.5513.2315.64
EPS (Diluted)15.5513.2315.51
EBITDA25,76323,06028,076
Other After Tax Adjustments
Stock Option Compensation Expense
Price To Earnings Ratio26.4324.9532.62
Price To Sales Ratio0.830.671.17
Gross Margin22.4918.5322.33
Operating Margin4.824.248.07
Net Margin3.142.693.60
Shares Outstanding906910929
Market Capitalization372,402300,400469,944
Operating Lease Expense
Unlock full historical data
See years of past statements with Premium.
Unlock with Premium
Insider Trading Volume
$466.14$401.60$337.06$272.52$207.98 Close Price0.00K71.00K142.00K213.00K284.00KUSD Trades VolumeAugSepOctNovDec2026FebMarAprMayJunJulAug
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Conway Patrick HughChief Executive Officer, OptumAug 05 '26Sale410.00500205,00016,497Aug 07
Conway Patrick HughChief Executive Officer, OptumApr 23 '26Sale355.00800284,00017,805Apr 27
Baker Charles D.DirectorSep 11 '25Sale356.05279,6130Sep 15
Conway Patrick HughChief Executive Officer, OptumJun 10 '25Sale305.00589179,64510,398Jun 12
REX JOHN FPresident & CFOMay 16 '25Buy291.1217,1754,999,919203,796May 16
HEMSLEY STEPHEN JCEO, UHGMay 16 '25Buy288.5786,70025,019,019679,493May 16
Gil KristenDirectorMay 15 '25Buy271.173,7001,003,3293,818May 16
Noseworthy John HDirectorMay 14 '25Buy312.1630093,6476,063May 16
FLYNN TIMOTHY PATRICKDirectorMay 14 '25Buy320.801,533491,7866,033May 16
REX JOHN FPresident & CFOFeb 07 '25Option Exercise108.9725,5042,779,171191,691Feb 07
FLYNN TIMOTHY PATRICKDirectorJan 17 '25Buy511.571,000511,5754,500Jan 22
McSweeney ErinEVP & Chief People OfficerNov 11 '24Sale626.23701438,9877,105Nov 13
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.